These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1071409)

  • 1. Centrally acting alpha-adrenoceptor agonists in hypertension: mechanisms and their role in therapy.
    Dollery CT
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):88-94. PubMed ID: 1071409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The plasma noradrenaline and growth hormone response to alpha-methyldopa and clonidine in hypertensive subjects.
    Struthers AD; Brown MJ; Adams EF; Dollery CT
    Br J Clin Pharmacol; 1985 Mar; 19(3):311-7. PubMed ID: 3986086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine.
    van Zwieten PA; Thoolen MJ; Timmermans PB
    Hypertension; 1984; 6(5 Pt 2):II28-33. PubMed ID: 6094346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine and methyldopa--any role for hypertension now?
    Drug Ther Bull; 1984 Jun; 22(11):42-3. PubMed ID: 6745097
    [No Abstract]   [Full Text] [Related]  

  • 6. Centrally acting alpha-2 agonists, peripherally acting adrenergic-blocking drugs, and direct vasodilators in the treatment of mild and moderate essential hypertension.
    Brown J; Branche G; Streets M; King A; Dowdy V; Batts J
    Clin Cardiol; 1989 Dec; 12(12 Suppl 4):IV78-81. PubMed ID: 2620475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The involvement of central alpha adrenoceptors in the antihypertensive actions of methyldopa and clonidine in the rat.
    Jarrott B; Lewis S; Conway EL; Summers R; Louis WJ
    Clin Exp Hypertens A; 1984; 6(1-2):387-400. PubMed ID: 6321066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitation by yohimbine of the withdrawal syndromes of clonidine, guanfacine, and methyldopa in the spontaneously hypertensive rat.
    Thoolen MJ; Hendriks JC; Timmermans PB; van Zwieten PA
    J Cardiovasc Pharmacol; 1983; 5(2):224-8. PubMed ID: 6188894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New concepts on central regulation of the blood pressure. Mode of action of clonidine and alpha-methyl DOPA (author's transl)].
    Kobinger W
    Wien Klin Wochenschr; 1977 Apr; 89(8):253-7. PubMed ID: 193305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.
    Elliott HL; McLean K; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1983; 24(1):15-9. PubMed ID: 6299752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans.
    Brown MJ; Harland D; Murphy MB; Struthers AD
    Hypertension; 1984; 6(5 Pt 2):II57-62. PubMed ID: 6150000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of clonidine hydrochloride (Catapres). A new antihypertensive agent.
    Kosman ME
    JAMA; 1975 Jul; 233(2):174-6. PubMed ID: 1173448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clonidine and methyldopa on blood pressure and side effects in hypertensive patients.
    Putzeys MR; Hoobler SW
    Am Heart J; 1972 Apr; 83(4):464-8. PubMed ID: 5041833
    [No Abstract]   [Full Text] [Related]  

  • 15. Clonidine hydrochloride: review of pharmacologic and clinical aspects.
    Houston MC
    Prog Cardiovasc Dis; 1981; 23(5):337-50. PubMed ID: 7012927
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of centrally acting sympatholytic agents in the management of hypertension.
    Oster JR; Epstein M
    Arch Intern Med; 1991 Aug; 151(8):1638-44. PubMed ID: 1872668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists.
    Reid JL; Campbell BC; Hamilton CA
    Hypertension; 1984; 6(5 Pt 2):II71-5. PubMed ID: 6150002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of therapeutic modalities acting directly via central pathways.
    Oparil S
    Clin Exp Hypertens A; 1982; 4(4-5):579-93. PubMed ID: 6125282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally acting alpha-agonists. Mechanisms and their role in the therapy of essential hypertension.
    Aust N Z J Med; 1976 Aug; 6(3 Suppl):98-101. PubMed ID: 1071410
    [No Abstract]   [Full Text] [Related]  

  • 20. Centrally acting antihypertensive agents: an update.
    Sica DA
    J Clin Hypertens (Greenwich); 2007 May; 9(5):399-405. PubMed ID: 17485976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.